Nuvalent (NUVL) EPS (Basic) (2020 - 2026)

Nuvalent (NUVL) posted EPS (Basic) of -$1.39 for Q1 2026, down 249.2% on a QoQ basis from -$0.4 in Q4 2025, and down 17.6% year-over-year from -$1.69 in Q1 2025.

Nuvalent (NUVL) EPS (Basic) (2020 - 2026) Analysis & Trends

Nuvalent's EPS (Basic) history runs 7 years deep, the most recent figure standing at -$1.39 for Q1 2026.

  • Quarterly EPS (Basic) fell 17.6% year-over-year to -$1.39 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.58 (down 9.0% YoY) and the FY2025 annual result came in at -$4.62, down 17.58% from the prior year.
  • EPS (Basic) was -$1.39 for Q1 2026 at Nuvalent, down from -$0.4 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$0.38 in Q1 2022 and bottomed at -$1.7 in Q3 2025.
  • A 5-year average of -$0.82 and a median of -$0.66 in 2023 frame the typical range for EPS (Basic).
  • Annual changes were most pronounced in 2022 — EPS (Basic) surged 87.21% — and 2024, when it slumped 117.91%.
  • Nuvalent's EPS (Basic) stood at -$0.55 in 2022, then retreated by 18.95% to -$0.66 in 2023, then slumped by 71.18% to -$1.13 in 2024, then surged by 64.67% to -$0.4 in 2025, then slumped by 249.2% to -$1.39 in 2026.
  • Business Quant data shows NUVL's EPS (Basic) at -$1.39 in Q1 2026, -$0.4 in Q4 2025, and -$1.7 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 0.00
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 0.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 0.16
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 4.06
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 6.99
7 Belite Bio 61.40 Bn 61.40 Bn - 0.00
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 5.90
9 Revolution Medicines 37.37 Bn 37.37 Bn - -2.29
10 Nuvalent 9.75 Bn 9.75 Bn - -1.39

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.39
Dec 31, 2025 -0.40
Sep 30, 2025 -1.70
Jun 30, 2025 -1.39
Mar 31, 2025 -1.18
Dec 31, 2024 -1.13
Sep 30, 2024 -1.28
Jun 30, 2024 -0.88
Mar 31, 2024 -0.69
Dec 31, 2023 -0.66
Sep 30, 2023 -0.59
Jun 30, 2023 -0.51
Mar 31, 2023 -0.44
Dec 31, 2022 -0.55
Sep 30, 2022 -0.43
Jun 30, 2022 -0.41
Mar 31, 2022 -0.38
Dec 31, 2021 -1.87
Sep 30, 2021 -0.39
Jun 30, 2021 -3.17